Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Samdani, S; Lachmann, E; Nagler, W
   Unilateral extremity swelling in female patients with cancer
   JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
   
   S. Samdani et al., "Unilateral extremity swelling in female patients with cancer", J WOMEN H G, 10(4), 2001, pp. 319-326
2. Axelrod, DA; Wakefield, TW
   Future directions in antithrombotic therapy: Emphasis on venous thromboembolism
   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
   
   D.A. Axelrod e T.W. Wakefield, "Future directions in antithrombotic therapy: Emphasis on venous thromboembolism", J AM COLL S, 192(5), 2001, pp. 641-651
3. Kalodiki, E; Calahoras, LS; Delis, KT; Zouzias, CP; Nicolaides, AN
   Air plethysmography: The answer in detecting past deep venous thrombosis
   JOURNAL OF VASCULAR SURGERY
   
   E. Kalodiki et al., "Air plethysmography: The answer in detecting past deep venous thrombosis", J VASC SURG, 33(4), 2001, pp. 715-720
4. Lopez-Beret, P; Orgaz, A; Fontcuberta, J; Doblas, M; Martinez, A; Lozano, G; Romero, A
   Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis
   JOURNAL OF VASCULAR SURGERY
   
   P. Lopez-Beret et al., "Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis", J VASC SURG, 33(1), 2001, pp. 77-90
5. Ginsberg, JS; Turpie, AGG
   Thromboembolism and pregnancy
   INTERNATIONAL ANGIOLOGY
   
   J.S. Ginsberg e A.G.G. Turpie, "Thromboembolism and pregnancy", INT ANGIOL, 20(2), 2001, pp. 103-109
6. Grau, E; Tenias, JM; Real, E; Medrano, J; Ferrer, R; Pastor, E; Selfa, S
   Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism
   AMERICAN JOURNAL OF HEMATOLOGY
   
   E. Grau et al., "Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism", AM J HEMAT, 67(1), 2001, pp. 10-14
7. Pineo, GF
   New developments in the prevention and treatment of venous thromboembolism
   PHARMACOTHERAPY
   
   G.F. Pineo, "New developments in the prevention and treatment of venous thromboembolism", PHARMACOTHE, 21(6), 2001, pp. 51S-55S
8. Rose, P; Bell, D; Green, ES; Davenports, A; Fegan, C; Grech, H; O'Shaughnessy, D; Voke, J
   The outcome of ambulatory DVT management using a multidisciplinary approach
   CLINICAL AND LABORATORY HAEMATOLOGY
   
   P. Rose et al., "The outcome of ambulatory DVT management using a multidisciplinary approach", CLIN LAB H, 23(5), 2001, pp. 301-306
9. Bates, SM; Weitz, JI; Johnston, M; Hirsh, J; Ginsberg, JS
   Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin
   ARCHIVES OF INTERNAL MEDICINE
   
   S.M. Bates et al., "Use of a fixed activated partial thromboplastin time ratio to establish a therapeutic range for unfractionated heparin", ARCH IN MED, 161(3), 2001, pp. 385-391
10. Menon, V; Berkowitz, SD; Antman, EM; Fuchs, RM; Hochman, JS
    New heparin dosing recommendations for patients with acute coronary syndromes
    AMERICAN JOURNAL OF MEDICINE
    
    V. Menon et al., "New heparin dosing recommendations for patients with acute coronary syndromes", AM J MED, 110(8), 2001, pp. 641-650
11. Rose, PE
    Anticoagulant therapy and referral form
    HOSPITAL MEDICINE
    
    P.E. Rose, "Anticoagulant therapy and referral form", HOSP MED, 61(9), 2000, pp. 643-646
12. Balcezak, TJ; Krumholz, HM; Getnick, GS; Vaccarino, V; Lin, ZQ; Cadman, EC
    Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center
    AMERICAN JOURNAL OF MANAGED CARE
    
    T.J. Balcezak et al., "Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center", AM J M CARE, 6(3), 2000, pp. 329-338
13. Tapson, VF
    Treatment of acute deep venous thrombosis and pulmonary embolism: Use of low molecular weight heparin
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    
    V.F. Tapson, "Treatment of acute deep venous thrombosis and pulmonary embolism: Use of low molecular weight heparin", SEM RESP CR, 21(6), 2000, pp. 547-553
14. Yazu, T; Fujioka, H; Nakamura, M; Hiraoka, N; Yamada, N; Ohta, M; Tanaka, H; Isaka, N; Nakano, T
    Long-term results of inferior vena cava filters: Experiences in a Japanesepopulation
    INTERNAL MEDICINE
    
    T. Yazu et al., "Long-term results of inferior vena cava filters: Experiences in a Japanesepopulation", INTERN MED, 39(9), 2000, pp. 707-714
15. Kelsey, LJ; Fry, DM; VanderKolk, WE
    Thrombosis risk in the trauma patient - Prevention and treatment
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    
    L.J. Kelsey et al., "Thrombosis risk in the trauma patient - Prevention and treatment", HEMAT ONCOL, 14(2), 2000, pp. 417
16. Partsch, H
    Ambulatory treatment of lower extremity venous thrombosis
    VASA-JOURNAL OF VASCULAR DISEASES
    
    H. Partsch, "Ambulatory treatment of lower extremity venous thrombosis", VASA, 29(1), 2000, pp. 3-4
17. Jerkeman, A; Astermark, J; Hedner, U; Lethagen, S; Olsson, CG; Berntorp, E
    Correlation between different intensities of anti-vitamin K treatment and coagulation parameters
    THROMBOSIS RESEARCH
    
    A. Jerkeman et al., "Correlation between different intensities of anti-vitamin K treatment and coagulation parameters", THROMB RES, 98(6), 2000, pp. 467-471
18. Kalafut, MA; Gandhi, R; Kidwell, CS; Saver, JL
    Safety and cost of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia
    STROKE
    
    M.A. Kalafut et al., "Safety and cost of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia", STROKE, 31(11), 2000, pp. 2563-2568
19. Hirsh, J; Bates, SM
    The emerging role of low-molecular-weight heparin in cardiovascular medicine
    PROGRESS IN CARDIOVASCULAR DISEASES
    
    J. Hirsh e S.M. Bates, "The emerging role of low-molecular-weight heparin in cardiovascular medicine", PROG CARD, 42(4), 2000, pp. 235-246
20. Della Valle, CJ; Jazrawi, LM; Idjadi, J; Hiebert, RN; Stuchin, SA; Steiger, DJ; Di Cesare, PE
    Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
    
    C.J. Della Valle et al., "Anticoagulant treatment of thromboembolism with intravenous heparin therapy in the early postoperative period following total joint arthroplasty", J BONE-AM V, 82A(2), 2000, pp. 207-212
21. Kitchen, S
    Problems in laboratory monitoring of heparin dosage
    BRITISH JOURNAL OF HAEMATOLOGY
    
    S. Kitchen, "Problems in laboratory monitoring of heparin dosage", BR J HAEM, 111(2), 2000, pp. 397-406
22. Zidane, M; Schram, MT; Planken, EW; Molendijk, WH; Rosendaal, FR; van der Meer, FJM; Huisman, MV
    Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice
    ARCHIVES OF INTERNAL MEDICINE
    
    M. Zidane et al., "Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice", ARCH IN MED, 160(15), 2000, pp. 2369-2373
23. Baron, RM; Goldhaber, SZ
    Deep venous thrombosis: Outpatient management is now FDA approved
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    
    R.M. Baron e S.Z. Goldhaber, "Deep venous thrombosis: Outpatient management is now FDA approved", J THROMB TH, 7(2), 1999, pp. 113-122
24. Fartoukh, M; Simonneau, G
    Use of anticoagulants in pulmonary embolism.
    REVUE DES MALADIES RESPIRATOIRES
    
    M. Fartoukh e G. Simonneau, "Use of anticoagulants in pulmonary embolism.", REV MAL RES, 16(5BIS), 1999, pp. 949-960
25. Ginsberg, JS
    Thromboembolism and pregnancy
    THROMBOSIS AND HAEMOSTASIS
    
    J.S. Ginsberg, "Thromboembolism and pregnancy", THROMB HAEM, 82(2), 1999, pp. 620-625
26. Lamy, O; Cornuz, J; Yersin, B
    Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis: a systematic review
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    
    O. Lamy et al., "Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis: a systematic review", SCHW MED WO, 129(18), 1999, pp. 707-714
27. Gould, MK; Dembitzer, AD; Sanders, GD; Garber, AM
    Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis
    ANNALS OF INTERNAL MEDICINE
    
    M.K. Gould et al., "Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis - A cost-effectiveness analysis", ANN INT MED, 130(10), 1999, pp. 789
28. Bartholomew, JR; Kottke-Marchant, K
    Monitoring anticoagulation therapy in patients with the lupus anticoagulant
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    
    J.R. Bartholomew e K. Kottke-Marchant, "Monitoring anticoagulation therapy in patients with the lupus anticoagulant", JCR-J CLIN, 4(6), 1998, pp. 307-311
29. PLANES A; VOCHELLE N; FAGOLA M; BELLAUD M
    COMPARISON OF 2 LOW-MOLECULAR-WEIGHT HEPARINS FOR THE PREVENTION OF POSTOPERATIVE VENOUS THROMBOEMBOLISM AFTER ELECTIVE HIP-SURGERY
    Blood coagulation & fibrinolysis
    
    A. Planes et al., "COMPARISON OF 2 LOW-MOLECULAR-WEIGHT HEPARINS FOR THE PREVENTION OF POSTOPERATIVE VENOUS THROMBOEMBOLISM AFTER ELECTIVE HIP-SURGERY", Blood coagulation & fibrinolysis, 9(6), 1998, pp. 499-505
30. Ansell, JE
    Oral anticoagulants for the treatment of venous thromboembolism
    BAILLIERES CLINICAL HAEMATOLOGY
    
    J.E. Ansell, "Oral anticoagulants for the treatment of venous thromboembolism", BAIL CLIN H, 11(3), 1998, pp. 639-661
31. KIRCHMAIER CM; WOLF H; SCHAFER H; EHLERS B; BREDDIN HK
    EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED INTRAVENOUSLYOR SUBCUTANEOUSLY IN COMPARISON WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS
    International angiology
    
    C.M. Kirchmaier et al., "EFFICACY OF A LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED INTRAVENOUSLYOR SUBCUTANEOUSLY IN COMPARISON WITH INTRAVENOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS", International angiology, 17(3), 1998, pp. 135-145
32. DEGROOT MR; BULLER HR; TENCATE JW; KOOY MV
    USE OF A HEPARIN NOMOGRAM FOR TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN A COMMUNITY-HOSPITAL
    Thrombosis and haemostasis
    
    M.R. Degroot et al., "USE OF A HEPARIN NOMOGRAM FOR TREATMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM IN A COMMUNITY-HOSPITAL", Thrombosis and haemostasis, 80(1), 1998, pp. 70-73
33. CAMPBELL NRC; HULL RD; BRANT R; HOGAN DB; PINEO GF; RASKOB GE
    DIFFERENT EFFECTS OF HEPARIN IN MALES AND FEMALES
    Clinical and investigative medicine
    
    N.R.C. Campbell et al., "DIFFERENT EFFECTS OF HEPARIN IN MALES AND FEMALES", Clinical and investigative medicine, 21(2), 1998, pp. 71-78
34. HAAS SK
    TREATMENT OF DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM - CURRENT RECOMMENDATIONS
    The Medical clinics of North America
    
    S.K. Haas, "TREATMENT OF DEEP VENOUS THROMBOSIS AND PULMONARY-EMBOLISM - CURRENT RECOMMENDATIONS", The Medical clinics of North America, 82(3), 1998, pp. 495
35. PINEO GF; HULL RD
    UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN - COMPARISONS AND CURRENT RECOMMENDATIONS
    The Medical clinics of North America
    
    G.F. Pineo e R.D. Hull, "UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN - COMPARISONS AND CURRENT RECOMMENDATIONS", The Medical clinics of North America, 82(3), 1998, pp. 587
36. GINSBERG JS; HIRSH J
    USE OF ANTITHROMBOTIC AGENTS DURING PREGNANCY
    Chest
    
    J.S. Ginsberg e J. Hirsh, "USE OF ANTITHROMBOTIC AGENTS DURING PREGNANCY", Chest, 114(5), 1998, pp. 524-530
37. HANSEN JB; SANDSET PM; HUSEBY KR; HUSEBY NE; BENDZ B
    DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION
    British Journal of Haematology
    
    J.B. Hansen et al., "DIFFERENTIAL EFFECT OF UNFRACTIONATED HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN ON INTRAVASCULAR TISSUE FACTOR PATHWAY INHIBITOR - EVIDENCE FOR A DIFFERENCE IN ANTITHROMBOTIC ACTION", British Journal of Haematology, 101(4), 1998, pp. 638-646
38. MUNGALL D
    ACTIVATED PARTIAL THROMBOPLASTIN TIME VS HEPARIN CONCENTRATION
    Archives of internal medicine
    
    D. Mungall, "ACTIVATED PARTIAL THROMBOPLASTIN TIME VS HEPARIN CONCENTRATION", Archives of internal medicine, 158(11), 1998, pp. 1273-1275
39. PRANDONI P; BAGATELLA P; BERNARDI E; GIROLAMI B; ROSSI L; SCARANO L; MARCHIORI A; PICCIOLI A; GIROLAMI A
    USE OF AN ALGORITHM FOR ADMINISTERING SUBCUTANEOUS HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS
    Annals of internal medicine
    
    P. Prandoni et al., "USE OF AN ALGORITHM FOR ADMINISTERING SUBCUTANEOUS HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS", Annals of internal medicine, 129(4), 1998, pp. 299-302
40. KEARON C; JULIAN JA; NEWMAN TE; GINSBERG JS
    NONINVASIVE DIAGNOSIS OF DEEP VENOUS THROMBOSIS
    Annals of internal medicine
    
    C. Kearon et al., "NONINVASIVE DIAGNOSIS OF DEEP VENOUS THROMBOSIS", Annals of internal medicine, 128(8), 1998, pp. 663-677
41. BIRDWELL BG; RASKOB GE; WHITSETT TL; DURICA SS; COMP PC; GEORGE JN; TYTLE TL; MCKEE PA
    THE CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF RAVING DEEP VENOUS THROMBOSIS
    Annals of internal medicine
    
    B.G. Birdwell et al., "THE CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF RAVING DEEP VENOUS THROMBOSIS", Annals of internal medicine, 128(1), 1998, pp. 1
42. MUNGALL D; LORD M; CASON S; TREADWELL P; WILLIAMS D; TEDRICK D
    DEVELOPING AND TESTING A SYSTEM TO IMPROVE THE QUALITY OF HEPARIN ANTICOAGULATION IN PATIENTS WITH ACUTE CARDIAC SYNDROMES
    The American journal of cardiology
    
    D. Mungall et al., "DEVELOPING AND TESTING A SYSTEM TO IMPROVE THE QUALITY OF HEPARIN ANTICOAGULATION IN PATIENTS WITH ACUTE CARDIAC SYNDROMES", The American journal of cardiology, 82(5), 1998, pp. 574-579
43. ADAMS HP; LEIRA EC
    ACUTE THERAPEUTIC INTERVENTION - ANTITHROMBOTIC AND ANTIPLATELET-AGGREGATING DRUGS
    Neurosurgery clinics of North America
    
    H.P. Adams e E.C. Leira, "ACUTE THERAPEUTIC INTERVENTION - ANTITHROMBOTIC AND ANTIPLATELET-AGGREGATING DRUGS", Neurosurgery clinics of North America, 8(2), 1997, pp. 207
44. HIRSH J; CROWTHER M
    LOW-MOLECULAR-WEIGHT HEPARIN FOR THE OUT-OF-HOSPITAL TREATMENT OF VENOUS THROMBOSIS - RATIONALE AND CLINICAL-RESULTS
    Thrombosis and haemostasis
    
    J. Hirsh e M. Crowther, "LOW-MOLECULAR-WEIGHT HEPARIN FOR THE OUT-OF-HOSPITAL TREATMENT OF VENOUS THROMBOSIS - RATIONALE AND CLINICAL-RESULTS", Thrombosis and haemostasis, 78(1), 1997, pp. 689-692
45. JANSSEN MCH; NOVAKOVA IRO; VERBRUGGEN H; WOLLERSHEIM H; THIEN T
    NEW DEVELOPMENTS IN THE TREATMENT OF DEEP VENOUS THROMBOSIS
    Netherlands journal of medicine
    
    M.C.H. Janssen et al., "NEW DEVELOPMENTS IN THE TREATMENT OF DEEP VENOUS THROMBOSIS", Netherlands journal of medicine, 50(1), 1997, pp. 36-45
46. TOH CH
    ANTICOAGULANTS FOR VENOUS THROMBOSIS
    Postgraduate medical journal
    
    C.H. Toh, "ANTICOAGULANTS FOR VENOUS THROMBOSIS", Postgraduate medical journal, 73(859), 1997, pp. 283-285
47. EBY C
    STANDARDIZATION OF APTT REAGENTS FOR HEPARIN-THERAPY MONITORING - URGENT OR FADING PRIORITY
    Clinical chemistry
    
    C. Eby, "STANDARDIZATION OF APTT REAGENTS FOR HEPARIN-THERAPY MONITORING - URGENT OR FADING PRIORITY", Clinical chemistry, 43(7), 1997, pp. 1105-1107
48. WHITE RH; ZHOU H; WOO L; MUNGALL D
    EFFECT OF WEIGHT, SEX, AGE, CLINICAL-DIAGNOSIS, AND THROMBOPLASTIN REAGENT ON STEADY-STATE INTRAVENOUS HEPARIN REQUIREMENTS
    Archives of internal medicine
    
    R.H. White et al., "EFFECT OF WEIGHT, SEX, AGE, CLINICAL-DIAGNOSIS, AND THROMBOPLASTIN REAGENT ON STEADY-STATE INTRAVENOUS HEPARIN REQUIREMENTS", Archives of internal medicine, 157(21), 1997, pp. 2468-2472
49. HULL RD; RASKOB GE; BRANT RF; PINEO GF; VALENTINE KA
    THE IMPORTANCE OF INITIAL HEPARIN TREATMENT ON LONG-TERM CLINICAL OUTCOMES OF ANTITHROMBOTIC THERAPY - THE EMERGING THEME OF DELAYED RECURRENCE
    Archives of internal medicine
    
    R.D. Hull et al., "THE IMPORTANCE OF INITIAL HEPARIN TREATMENT ON LONG-TERM CLINICAL OUTCOMES OF ANTITHROMBOTIC THERAPY - THE EMERGING THEME OF DELAYED RECURRENCE", Archives of internal medicine, 157(20), 1997, pp. 2317-2321
50. RASKOB GE; GEORGE JN
    THROMBOTIC COMPLICATIONS OF ANTITHROMBOTIC THERAPY - A PARADOX WITH IMPLICATIONS FOR CLINICAL-PRACTICE
    Annals of internal medicine
    
    G.E. Raskob e J.N. George, "THROMBOTIC COMPLICATIONS OF ANTITHROMBOTIC THERAPY - A PARADOX WITH IMPLICATIONS FOR CLINICAL-PRACTICE", Annals of internal medicine, 127(9), 1997, pp. 839-841
51. REILLY BM; RASCHKE RA
    NEW METHOD TO PREDICT PATIENTS INTRAVENOUS HEPARIN DOSE REQUIREMENTS
    Journal of general internal medicine
    
    B.M. Reilly e R.A. Raschke, "NEW METHOD TO PREDICT PATIENTS INTRAVENOUS HEPARIN DOSE REQUIREMENTS", Journal of general internal medicine, 11(3), 1996, pp. 168-173
52. KITCHEN S; PRESTON FE
    THE THERAPEUTIC RANGE FOR HEPARIN-THERAPY - RELATIONSHIP BETWEEN 6 ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS AND 2 HEPARIN ASSAYS
    Thrombosis and haemostasis
    
    S. Kitchen e F.E. Preston, "THE THERAPEUTIC RANGE FOR HEPARIN-THERAPY - RELATIONSHIP BETWEEN 6 ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS AND 2 HEPARIN ASSAYS", Thrombosis and haemostasis, 75(5), 1996, pp. 734-739
53. PARTSCH H
    DIAGNOSIS AND TREATMENT OF DEEP VENOUS TH ROMBOSIS
    VASA
    
    H. Partsch, "DIAGNOSIS AND TREATMENT OF DEEP VENOUS TH ROMBOSIS", VASA, 1996, pp. 5-53
54. TURPIE AGG
    MANAGEMENT OF VENOUS THROMBOEMBOLISM - OPTIMIZATION BY CLINICAL-TRIALS
    Haemostasis
    
    A.G.G. Turpie, "MANAGEMENT OF VENOUS THROMBOEMBOLISM - OPTIMIZATION BY CLINICAL-TRIALS", Haemostasis, 26, 1996, pp. 220-226
55. KRULDER JWM; VANDERMEER FJM; BRIET E; MEINDERS AE
    MONITORING HEPARIN TREATMENT WITH THE APTT - THE EFFECT OF METHODOLOGICAL CHANGES ON THE APTT
    Netherlands journal of medicine
    
    J.W.M. Krulder et al., "MONITORING HEPARIN TREATMENT WITH THE APTT - THE EFFECT OF METHODOLOGICAL CHANGES ON THE APTT", Netherlands journal of medicine, 49(1), 1996, pp. 13-18
56. SCHREIBER W; STUEHLINGER HG; BRUNNER M; HOLLENSTEIN U
    PRECLINICAL MANAGEMENT OF THROMBOEMBOLIC DISORDERS
    Seminars in thrombosis and hemostasis
    
    W. Schreiber et al., "PRECLINICAL MANAGEMENT OF THROMBOEMBOLIC DISORDERS", Seminars in thrombosis and hemostasis, 22(1), 1996, pp. 3-13
57. HYERS TM
    INTEGRATED MANAGEMENT OF VENOUS THROMBOEMBOLISM
    Southern medical journal
    
    T.M. Hyers, "INTEGRATED MANAGEMENT OF VENOUS THROMBOEMBOLISM", Southern medical journal, 89(1), 1996, pp. 20-26
58. LEIZOROVICZ A
    COMPARISON OF THE EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN THE INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - AN UPDATED METAANALYSIS
    Drugs
    
    A. Leizorovicz, "COMPARISON OF THE EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN THE INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - AN UPDATED METAANALYSIS", Drugs, 52, 1996, pp. 30-37
59. TROTTIER SJ; TODI S; VEREMAKIS C
    VALIDATION OF AN INEXPENSIVE B-MODE ULTRASOUND DEVICE FOR DETECTION OF DEEP-VEIN THROMBOSIS
    Chest
    
    S.J. Trottier et al., "VALIDATION OF AN INEXPENSIVE B-MODE ULTRASOUND DEVICE FOR DETECTION OF DEEP-VEIN THROMBOSIS", Chest, 110(6), 1996, pp. 1547-1550
60. BIEMOND BJ; FRIEDERICH PW; LEVI M; VLASUK GP; BULLER HR; TENCATE JW
    COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS
    Circulation
    
    B.J. Biemond et al., "COMPARISON OF SUSTAINED ANTITHROMBOTIC EFFECTS OF INHIBITORS OF THROMBIN AND FACTOR XA IN EXPERIMENTAL THROMBOSIS", Circulation, 93(1), 1996, pp. 153-160
61. CAMPBELL NRC; HULL RD; BRANT R; HOGAN DB; PINEO GF; RASKOB GE
    AGING AND HEPARIN-RELATED BLEEDING
    Archives of internal medicine
    
    N.R.C. Campbell et al., "AGING AND HEPARIN-RELATED BLEEDING", Archives of internal medicine, 156(8), 1996, pp. 857-860
62. HIRSCH DR; LEE TH; MORRISON RB; CARLSON W; GOLDHABER SZ
    SHORTENED HOSPITALIZATION BY MEANS OF ADJUSTED-DOSE SUBCUTANEOUS HEPARIN FOR DEEP VENOUS THROMBOSIS
    The American heart journal
    
    D.R. Hirsch et al., "SHORTENED HOSPITALIZATION BY MEANS OF ADJUSTED-DOSE SUBCUTANEOUS HEPARIN FOR DEEP VENOUS THROMBOSIS", The American heart journal, 131(2), 1996, pp. 276-280
63. BEYTH RJ; LANDEFELD CS
    ANTICOAGULANTS IN OLDER PATIENTS - A SAFETY PERSPECTIVE
    Drugs & aging
    
    R.J. Beyth e C.S. Landefeld, "ANTICOAGULANTS IN OLDER PATIENTS - A SAFETY PERSPECTIVE", Drugs & aging, 6(1), 1995, pp. 45-54
64. DAHL OE; ASPELIN T; LYBERG T
    THE ROLE OF BONE TRAUMATIZATION IN THE INITIATION OF PROXIMAL DEEP-VEIN THROMBOSIS DURING CEMENTED HIP-REPLACEMENT SURGERY IN PIGS
    Blood coagulation & fibrinolysis
    
    O.E. Dahl et al., "THE ROLE OF BONE TRAUMATIZATION IN THE INITIATION OF PROXIMAL DEEP-VEIN THROMBOSIS DURING CEMENTED HIP-REPLACEMENT SURGERY IN PIGS", Blood coagulation & fibrinolysis, 6(8), 1995, pp. 709-717
65. MEISSNER MH; CAPS MT; BERGELIN RO; MANZO RA; STRANDNESS DE
    PROPAGATION, RETHROMBOSIS AND NEW THROMBUS FORMATION AFTER ACUTE DEEPVENOUS THROMBOSIS
    Journal of vascular surgery
    
    M.H. Meissner et al., "PROPAGATION, RETHROMBOSIS AND NEW THROMBUS FORMATION AFTER ACUTE DEEPVENOUS THROMBOSIS", Journal of vascular surgery, 22(5), 1995, pp. 558-567
66. BENTOLILA S; RADENNE S; HORELLOU MH; CONARD J; SAMAMA MM
    HEMORRHAGIC COMPLICATIONS OF ORAL ANTICOA GULATION
    Journal des maladies vasculaires
    
    S. Bentolila et al., "HEMORRHAGIC COMPLICATIONS OF ORAL ANTICOA GULATION", Journal des maladies vasculaires, 20(2), 1995, pp. 95-101
67. HIRSH J
    HEPARINS
    Fibrinolysis
    
    J. Hirsh, "HEPARINS", Fibrinolysis, 9, 1995, pp. 66-68
68. HANDLER JA; FEIED CF
    ACUTE PULMONARY-EMBOLISM - AGGRESSIVE THERAPY WITH ANTICOAGULANTS ANDTHROMBOLYTICS .3.
    Postgraduate medicine
    
    J.A. Handler e C.F. Feied, "ACUTE PULMONARY-EMBOLISM - AGGRESSIVE THERAPY WITH ANTICOAGULANTS ANDTHROMBOLYTICS .3.", Postgraduate medicine, 97(1), 1995, pp. 61
69. COMEROTA AJ
    MODERN-DAY TREATMENT OF ACUTE DEEP VENOUS THROMBOSIS
    Australian and New Zealand journal of surgery
    
    A.J. Comerota, "MODERN-DAY TREATMENT OF ACUTE DEEP VENOUS THROMBOSIS", Australian and New Zealand journal of surgery, 65(11), 1995, pp. 773-779
70. LENSING AWA; PRINS MH; DAVIDSON BL; HIRSH J
    TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW-MOLECULAR-WEIGH HEPARINS- A METAANALYSIS
    Archives of internal medicine
    
    A.W.A. Lensing et al., "TREATMENT OF DEEP VENOUS THROMBOSIS WITH LOW-MOLECULAR-WEIGH HEPARINS- A METAANALYSIS", Archives of internal medicine, 155(6), 1995, pp. 601-607
71. HULL RD; RASKOB GE; PINCO GF; BRANT RF
    THE LOW-PROBABILITY LUNG-SCAN - A NEED FOR CHANGE IN NOMENCLATURE
    Archives of internal medicine
    
    R.D. Hull et al., "THE LOW-PROBABILITY LUNG-SCAN - A NEED FOR CHANGE IN NOMENCLATURE", Archives of internal medicine, 155(17), 1995, pp. 1845-1851
72. SCHIELE F; VUILLEMENOT A; MOUHAT T; KRAMARZ P; KIEFFER Y; CAMEZ A; BASSAND JP
    SUBCUTANEOUS RECOMBINANT HIRUDIN IN THE T REATMENT OF DEEP VENOUS THROMBOSIS - A PHARMACOKINETIC STUDY
    Archives des maladies du coeur et des vaisseaux
    
    F. Schiele et al., "SUBCUTANEOUS RECOMBINANT HIRUDIN IN THE T REATMENT OF DEEP VENOUS THROMBOSIS - A PHARMACOKINETIC STUDY", Archives des maladies du coeur et des vaisseaux, 88(3), 1995, pp. 329-335
73. LENGFELDER W
    CURRENT STATUS OF ANTITHROMBOTIC TREATMEN T
    Deutsche Medizinische Wochenschrift
    
    W. Lengfelder, "CURRENT STATUS OF ANTITHROMBOTIC TREATMEN T", Deutsche Medizinische Wochenschrift, 120(4), 1995, pp. 105-110
74. LEIZOROVICZ A; SIMONNEAU G; DECOUSUS H; BOISSEL JP
    COMPARISON OF EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - A METAANALYSIS
    BMJ. British medical journal
    
    A. Leizorovicz et al., "COMPARISON OF EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN IN INITIAL TREATMENT OF DEEP VENOUS THROMBOSIS - A METAANALYSIS", BMJ. British medical journal, 309(6950), 1994, pp. 299-304
75. PINEDE L; NINET J; BOISSEL JP; PASQUIER J
    ANTICOAGULANT-THERAPY FOR VENOUS THROMBOE MBOLISM - OPTIMAL DURATION OF ORAL ANTIVITAMIN-K
    La Presse medicale
    
    L. Pinede et al., "ANTICOAGULANT-THERAPY FOR VENOUS THROMBOE MBOLISM - OPTIMAL DURATION OF ORAL ANTIVITAMIN-K", La Presse medicale, 23(39), 1994, pp. 1817-1820
76. MEYER G; FARGE D; SAUVAGET F; DIEHL JL; HERVE R; ROUFFY J; SORS H
    THROMBOEMBOLISM AND CANCER
    La Presse medicale
    
    G. Meyer et al., "THROMBOEMBOLISM AND CANCER", La Presse medicale, 23(38), 1994, pp. 1767-1771
77. RUBIN BG; REILLY JM; SICARD GA; BOTNEY MD
    CARE OF PATIENTS WITH DEEP VENOUS THROMBOSIS IN AN ACADEMIC-MEDICAL-CENTER - LIMITATIONS AND LESSONS
    Journal of vascular surgery
    
    B.G. Rubin et al., "CARE OF PATIENTS WITH DEEP VENOUS THROMBOSIS IN AN ACADEMIC-MEDICAL-CENTER - LIMITATIONS AND LESSONS", Journal of vascular surgery, 20(5), 1994, pp. 698-704
78. YOUNG E; WELLS P; HOLLOWAY S; WEITZ J; HIRSH J
    EX-VIVO AND IN-VITRO EVIDENCE THAT LOW-MOLECULAR-WEIGHT HEPARINS EXHIBIT LESS BINDING TO PLASMA-PROTEINS THAN UNFRACTIONATED HEPARIN
    Thrombosis and haemostasis
    
    E. Young et al., "EX-VIVO AND IN-VITRO EVIDENCE THAT LOW-MOLECULAR-WEIGHT HEPARINS EXHIBIT LESS BINDING TO PLASMA-PROTEINS THAN UNFRACTIONATED HEPARIN", Thrombosis and haemostasis, 71(3), 1994, pp. 300-304
79. MONREAL M; LAFOZ E; OLIVE A; DELRIO L; VEDIA C
    COMPARISON OF SUBCUTANEOUS UNFRACTIONATED HEPARIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND CONTRAINDICATIONS TO COUMARIN
    Thrombosis and haemostasis
    
    M. Monreal et al., "COMPARISON OF SUBCUTANEOUS UNFRACTIONATED HEPARIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND CONTRAINDICATIONS TO COUMARIN", Thrombosis and haemostasis, 71(1), 1994, pp. 7-11
80. HULL RD; PINEO GF
    THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - KNOWLEDGE TO DATE AND THEIR APPLICATION TO THERAPY
    Seminars in thrombosis and hemostasis
    
    R.D. Hull e G.F. Pineo, "THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - KNOWLEDGE TO DATE AND THEIR APPLICATION TO THERAPY", Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 339-344
81. NIELSEN HK; HUSTED SE; KRUSELL LR; FASTING H; CHARLES P; HANSEN HH; NIELSEN BO; PETERSEN JB; BECHGAARD P
    ANTICOAGULANT-THERAPY IN DEEP VENOUS THROMBOSIS - A RANDOMIZED CONTROLLED-STUDY
    Thrombosis research
    
    H.K. Nielsen et al., "ANTICOAGULANT-THERAPY IN DEEP VENOUS THROMBOSIS - A RANDOMIZED CONTROLLED-STUDY", Thrombosis research, 73(3-4), 1994, pp. 215-226
82. STEIN PD; HULL RD
    RELATIVE RISKS OF ANTICOAGULANT TREATMENT OF ACUTE PULMONARY-EMBOLISMBASED ON AN ANGIOGRAPHIC DIAGNOSIS VS A VENTILATION PERFUSION SCAN DIAGNOSIS/
    Chest
    
    P.D. Stein e R.D. Hull, "RELATIVE RISKS OF ANTICOAGULANT TREATMENT OF ACUTE PULMONARY-EMBOLISMBASED ON AN ANGIOGRAPHIC DIAGNOSIS VS A VENTILATION PERFUSION SCAN DIAGNOSIS/", Chest, 106(3), 1994, pp. 727-730
83. STEIN PD; HULL RD; RASKOB G
    RISKS FOR MAJOR BLEEDING FROM THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM - CONSIDERATION OF NONINVASIVE MANAGEMENT
    Annals of internal medicine
    
    P.D. Stein et al., "RISKS FOR MAJOR BLEEDING FROM THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM - CONSIDERATION OF NONINVASIVE MANAGEMENT", Annals of internal medicine, 121(5), 1994, pp. 313-317
84. BROPHY MT; FIORE LD; LAU J; GOODWIN R; LOPEZ A; DEYKIN D
    COMPARISON OF A STANDARD AND A SENSITIVE THROMBOPLASTIN IN MONITORINGLOW-INTENSITY ORAL ANTICOAGULANT-THERAPY
    American journal of clinical pathology
    
    M.T. Brophy et al., "COMPARISON OF A STANDARD AND A SENSITIVE THROMBOPLASTIN IN MONITORINGLOW-INTENSITY ORAL ANTICOAGULANT-THERAPY", American journal of clinical pathology, 102(1), 1994, pp. 134-137
85. MONREAL M; LAFOZ E; RUIZ J; GIMENEZ G
    PLATELET COUNT IN ACUTE PULMONARY-EMBOLISM - ITS RELATIONSHIP TO RECURRENCES
    Haemostasis
    
    M. Monreal et al., "PLATELET COUNT IN ACUTE PULMONARY-EMBOLISM - ITS RELATIONSHIP TO RECURRENCES", Haemostasis, 23(5), 1993, pp. 263-268
86. HULL RD; PINEO GF
    THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - THE KNOWLEDGE TO DATE AS APPLIED TO THERAPY
    Seminars in thrombosis and hemostasis
    
    R.D. Hull e G.F. Pineo, "THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - THE KNOWLEDGE TO DATE AS APPLIED TO THERAPY", Seminars in thrombosis and hemostasis, 19, 1993, pp. 111-115
87. BECKER RC; GORE JM
    THE CHALLENGE OF MAINTAINING CORONARY ARTERIAL PATENCY WITH INTRAVENOUS HEPARIN FOLLOWING TISSUE-PLASMINOGEN ACTIVATOR ADMINISTRATION
    Cardiology
    
    R.C. Becker e J.M. Gore, "THE CHALLENGE OF MAINTAINING CORONARY ARTERIAL PATENCY WITH INTRAVENOUS HEPARIN FOLLOWING TISSUE-PLASMINOGEN ACTIVATOR ADMINISTRATION", Cardiology, 83(1-2), 1993, pp. 100-106
88. MARCILLAC I; IBRAHIM A; HAYAT M
    THROMBOTIC DISORDERS IN CANCER-PATIENTS
    Bulletin du cancer
    
    I. Marcillac et al., "THROMBOTIC DISORDERS IN CANCER-PATIENTS", Bulletin du cancer, 80(10), 1993, pp. 845-851
89. SAOUR J; GALLUS A
    WARFARIN - IS IT TIME TO REDUCE TARGET RANGES AGAIN
    Australian and New Zealand Journal of Medicine
    
    J. Saour e A. Gallus, "WARFARIN - IS IT TIME TO REDUCE TARGET RANGES AGAIN", Australian and New Zealand Journal of Medicine, 23(6), 1993, pp. 692-696
90. RASCHKE RA; REILLY BM; GUIDRY JR; FONTANA JR; SRINIVAS S
    THE WEIGHT-BASED HEPARIN DOSING NOMOGRAM COMPARED WITH A STANDARD CARE NOMOGRAM - A RANDOMIZED CONTROLLED TRIAL
    Annals of internal medicine
    
    R.A. Raschke et al., "THE WEIGHT-BASED HEPARIN DOSING NOMOGRAM COMPARED WITH A STANDARD CARE NOMOGRAM - A RANDOMIZED CONTROLLED TRIAL", Annals of internal medicine, 119(9), 1993, pp. 874-881
91. BRILLEDWARDS P; GINSBERG JS; JOHNSTON M; HIRSH J
    ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY
    Annals of internal medicine
    
    P. Brilledwards et al., "ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY", Annals of internal medicine, 119(2), 1993, pp. 104-109